Antibiotic Prophylaxis With Routine Ureteral Stent Removal (STENTABX)
Urolithiasis, UTI
About this trial
This is an interventional prevention trial for Urolithiasis focused on measuring Urolithiasis, UTI
Eligibility Criteria
Age: >=18 years of age
Gender: both men and women included. We anticipated enrolling a study population of approximately 60% men and 40% women based on a higher incidence of kidney stones among men in NHANES data.
Ethnic background: all ethnicities will be included in the study population and the specific ethnic diversity present in the study population will reflect the geographic distributions of the participating institutions.
Health Status: see below for specific inclusion/exclusion criteria.
Inclusion criteria:
- Patients with indwelling ureteral stents placed within the 2 weeks prior to the procedure visit for removal
- Patients having underwent kidney stone treatment surgery (shockwave lithotripsy [SWL], ureteroscopy [URS], retrograde intrarenal surgery [RIRS], percutaneous nephrolithotomy [PNL]) Exclusion criteria
- Patients with indwelling urethral catheter
- Patients with indwelling suprapubic catheter
- Patients with indwelling nephrostomy tube
- Patients who perform clean intermittent catheterization
- Pregnancy
Sites / Locations
- University of California, San DiegoRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Antibiotic
No Antibiotic
Patients randomized to the intervention arm will be provided a single oral dose of prophylactic oral antibiotic at the time of cystoscopic stent removal
Patients randomized to the non-intervention arm will not undergo prophylaxis at the time of cystoscopic stent removal